Free Trial

This company has been marked as potentially delisted and may not be actively trading.

resTORbio (TORC) Competitors

resTORbio logo

TORC vs. WHWK, VIRI, PYRGF, VHAQ, AADI, OSTX, NBRV, ATNM, EGRX, and ELYM

Should you be buying resTORbio stock or one of its competitors? The main competitors of resTORbio include Whitehawk Therapeutics (WHWK), Virios Therapeutics (VIRI), PyroGenesis Canada (PYRGF), Viveon Health Acquisition (VHAQ), Aadi Bioscience (AADI), OS Therapies (OSTX), Nabriva Therapeutics (NBRV), Actinium Pharmaceuticals (ATNM), Eagle Pharmaceuticals (EGRX), and Eliem Therapeutics (ELYM).

resTORbio vs. Its Competitors

Whitehawk Therapeutics (NASDAQ:WHWK) and resTORbio (NASDAQ:TORC) are both small-cap pharmaceutical preparations industry companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

Whitehawk Therapeutics has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500. Comparatively, resTORbio has a beta of 2.43, meaning that its share price is 143% more volatile than the S&P 500.

In the previous week, Whitehawk Therapeutics' average media sentiment score of 0.00 equaled resTORbio'saverage media sentiment score.

Company Overall Sentiment
Whitehawk Therapeutics Neutral
resTORbio Neutral

52.1% of Whitehawk Therapeutics shares are held by institutional investors. Comparatively, 46.2% of resTORbio shares are held by institutional investors. 49.9% of Whitehawk Therapeutics shares are held by insiders. Comparatively, 11.8% of resTORbio shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Whitehawk Therapeutics has higher revenue and earnings than resTORbio. resTORbio is trading at a lower price-to-earnings ratio than Whitehawk Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Whitehawk Therapeutics$25.98M3.61-$63.69M$0.1612.44
resTORbioN/AN/A-$82.74M-$2.41-0.28

Whitehawk Therapeutics has a net margin of 99.42% compared to resTORbio's net margin of 0.00%. Whitehawk Therapeutics' return on equity of -56.73% beat resTORbio's return on equity.

Company Net Margins Return on Equity Return on Assets
Whitehawk Therapeutics99.42% -56.73% -48.68%
resTORbio N/A -78.12%-71.63%

Summary

Whitehawk Therapeutics beats resTORbio on 8 of the 9 factors compared between the two stocks.

Get resTORbio News Delivered to You Automatically

Sign up to receive the latest news and ratings for TORC and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TORC vs. The Competition

MetricresTORbioPharmaceutical Preparations IndustryMedical SectorNASDAQ Exchange
Market Cap$24.89M$820.66M$5.50B$8.94B
Dividend YieldN/A4.84%5.25%4.04%
P/E Ratio-0.381.0926.9720.11
Price / SalesN/A230.52426.02119.76
Price / CashN/A23.4436.8257.86
Price / Book0.306.137.985.56
Net Income-$82.74M-$27.85M$3.16B$248.40M

resTORbio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TORC
resTORbio
N/A$0.68
+5.2%
N/A-39.3%$24.89MN/A-0.38N/A
WHWK
Whitehawk Therapeutics
N/A$1.99
+0.5%
N/AN/A$93.28M$25.98M0.0040
VIRI
Virios Therapeutics
N/A$4.80
-0.6%
$5.00
+4.2%
+1,782.4%$92.44MN/A-17.785
PYRGF
PyroGenesis Canada
0.1034 of 5 stars
$0.35
-2.5%
N/A-43.0%$64.48M$9.14M-5.7690News Coverage
VHAQ
Viveon Health Acquisition
N/A$11.00
flat
N/A+10.0%$62.26MN/A0.002High Trading Volume
AADI
Aadi Bioscience
0.6374 of 5 stars
$1.98
-0.5%
$1.67
-15.8%
+44.5%$48.90M$25.07M-0.8740
OSTX
OS Therapies
2.7865 of 5 stars
$1.62
-6.4%
$18.00
+1,011.1%
N/A$45.52MN/A-1.88N/A
NBRV
Nabriva Therapeutics
N/AN/AN/AN/A$45.46M$35.59M0.0070
ATNM
Actinium Pharmaceuticals
2.9555 of 5 stars
$1.43
+0.7%
$4.00
+179.7%
N/A$44.61MN/A-1.0330
EGRX
Eagle Pharmaceuticals
N/A$3.25
+8.3%
N/A-45.9%$42.21M$257.55M0.00100
ELYM
Eliem Therapeutics
N/A$1.28
+1.6%
N/A-81.1%$38.08MN/A-2.429

Related Companies and Tools


This page (NASDAQ:TORC) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners